Silver Book Fact

The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.

Russell J, Holman A, Swick T, Alvarez-Horine S, et al. Sodium Oxybate Reduces Pain, Fatigue, and Sleep Disturbance and Improves Functionality in Fibromyalgia: Results from a 14-week randomized, double-blind, placebo-controlled study. Pain. 2011; 152(5): 1007-17. https://insights.ovid.com/pubmed?pmid=21397402

Reference

Title
Sodium Oxybate Reduces Pain, Fatigue, and Sleep Disturbance and Improves Functionality in Fibromyalgia: Results from a 14-week randomized, double-blind, placebo-controlled study
Publication
Pain
Publication Date
2011
Authors
Russell J, Holman A, Swick T, Alvarez-Horine S, et al
Volume & Issue
Volume 152, Issue 5
Pages
1007-17
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Opioids have been found to reduce pain intensity and improve physical functioning for patients with persistent noncancer pain. It’s important to note that a decrease in mental health functioning…  
  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.  
  • Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.  
  • Statin use in mouse models show pain-alleviating effects for neuropathic pain.  
  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.